Skip to main content
Clinical Trials/NCT05896202
NCT05896202CompletedNot Applicable

Addressing Disparities in Neuromodulation for Rehabilitation: A Mixed Methods Approach to Optimize Access for Underrepresented Racial Minorities

University of Miami1 site in 1 country28 target enrollmentStarted: January 15, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
28
Locations
1
Primary Endpoint
Change Expectation for Pain Relief as Measured by EXPECT Scores

Study Overview

Brief Summary

The purpose of this study is to:

  1. Development of culturally sensitive videos for enhance informed consent with neurostimulation and determination of factors that influence minority interest in participating in neurostimulation research.
  2. Examination of the influence that video enhanced informed consent has on expectations with transcutaneous auricular vagus nerve stimulation (taVNS) and on treatment intended effects.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •between the ages of 18-80 years
  • •neuropathic pain lasting longer than 3 months (i.e., complaint of sensation of burning, stabbing or pressing pain, shooting or shock like pain, or paresthesias)
  • •Neuropathic Pain Symptom Inventory score ≥
  • •self identifies as Black or Hispanic

Exclusion Criteria

  • •any unstable medical condition or medical contraindication to moderate physical exertion (e.g., unstable angina or cardiac arrythmia)
  • •currently taking Buprenorphine or recently stopped taking (within 1 month)
  • •presence of cognitive impairment or language barrier that impairs full autonomy in the consent process or in the ability to participate in detailed interviews
  • •implants in the head or neck, cochlear implants, or pacemaker
  • •head or neck metastasis or recent ear trauma
  • •history of seizures.

Arms & Interventions

Transcutaneous Auricular Vagus Nerve stimulation (taVNS) group

Experimental

This group will receive supplemental videos on taVNS and TMS. Participants will be in this group for approximately 7 hours.

Intervention: taVNS Video (Other)

Transcutaneous Auricular Vagus Nerve stimulation (taVNS) group

Experimental

This group will receive supplemental videos on taVNS and TMS. Participants will be in this group for approximately 7 hours.

Intervention: Educational materials (Other)

Transcranial Magnetic Stimulation (TMS) group

Active Comparator

This group will receive a supplemental video on TMS only. Participants will be in this group for approximately 7 hours.

Intervention: Educational materials (Other)

Transcranial Magnetic Stimulation (TMS) group

Active Comparator

This group will receive a supplemental video on TMS only. Participants will be in this group for approximately 7 hours.

Intervention: TMS Video (Other)

Outcomes

Primary Outcomes

Change Expectation for Pain Relief as Measured by EXPECT Scores

Time Frame: Baseline, and up to 90 minutes

The Expectations for Complementary and Alternative Medicine Treatments (EXPECT) is a 4-item questionnaire that assesses expectations for pain improvement. Each of the 4 items is scored on an 11-point scale, with 0 being no change and 10 representing complete relief (scores ranging from 0-10). Higher scores represent greater expectations for pain relief. Scores from all 4 items are summed to produce a total score ranging from 0 to 40, with higher scores indicating greater expectations for pain relief.

Secondary Outcomes

  • Change in Heart Rate Variability (HRV)(Baseline, up to 90 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marlon Wong

Associate Professor of Clinical Physical Therapy

University of Miami

Study Sites (1)

Loading locations...

Similar Trials